News Grower

Independent coverage of AI, startups, and technology.

Ars Technica Apr 17, 2026 at 19:19 Big Tech Stable Warm

Trump picks qualified, normal health leader to head CDC; experts still cautious

She's well qualified but will need to navigate RFK Jr.'s anti-vaccine agenda.

Signal weather

Stable

The story has moved beyond the first headline and now acts as a reliable context anchor.

By Beth Mole Original source
Trump picks qualified, normal health leader to head CDC; experts still cautious

President Trump on Thursday announced his third nominee for director of the Centers for Disease Control and Prevention: Dr. Erica Schwartz, a well-qualified former public health official and board-certified physician in preventive medicine, who has publicly supported vaccination and followed evidence-based medicine. The uncontroversial pick comes amid concern within the administration that the aggressive anti-vaccine agenda from Health Secretary Robert F. Kennedy Jr.—who has no medical, science, or public health background—has become a liability for the party in the lead up to the midterms. Schwartz was deputy surgeon general in Trump's first administration. She spent much of her career as a Navy officer, held the role of Chief Medical Officer with the US Coast Guard, and is a retired rear admiral of the US Public Health Service Commissioned Corps. She has a medical degree from Brown University, a master's degree in public health, and a law degree from the University of Maryland. During the pandemic, she was involved in the federal rollout of COVID-19 vaccines. Read full article Comments

Stay on the signal

Follow Trump picks qualified, normal health leader to head CDC; experts still cautious

Follow this story beyond a single article: new follow-ups, adjacent sources, and the evolving storyline.

We send a confirmation link first, then only meaningful digests.

Story map

Understand this topic fast

A quick entry into the story: why it matters now, who is involved, and where to go next for context.

Why it matters now

This story is still moving and pulling follow-up coverage.
There are already 6 connected articles in the same storyline to continue from here.
The story keeps orbiting around Anti Vaccine, Anti Vaccine Agenda, and Ars Technica, so the entity pages are the fastest way to build context.
Ars Technica already has 4 follow-up stories on the same theme.

Topic constellation

Open the live map for this story

See which entities, story threads, sources, and follow-up articles shape this story right now.

Click nodes to continue

Entity Cluster Article Hub Source

Story timeline

Continue with this story

A short sequence of events and follow-up stories to understand the arc quickly.

Jun 13, 2026 at 11:18 Ars Technica

Threads of underground fungal networks are long enough to reach beyond the Solar System

Researchers have quantified the length and mass of arbuscular mycorrhizal fungal networks globally.

Jun 13, 2026 at 03:00 Ars Technica

Anthropic shuts down Fable, Mythos models following Trump admin directive

Commerce dept. worries that a Fable 5 "jailbreak" could be a national security threat.

Jun 12, 2026 at 22:20 Ars Technica

SpaceX is now a public company valued for its AI potential, so what comes next?

As of today, SpaceX is owned by investors who will want to see it make money.

Jun 12, 2026 at 19:26 Ars Technica

PeopleSoft 0-day affecting hundreds of organizations steals gigabytes of data

Vulnerability in the Oracle-owned PeopleSoft software is about as critical as they come.

Jun 12, 2026 at 18:57 Ars Technica

Controversial FISA spying law expires tonight. The spying will continue.

Section 702 of FISA to expire tonight, but certification lasts until March 2027.

Apr 17, 2026 at 19:19 Ars Technica

Trump picks qualified, normal health leader to head CDC; experts still cautious

She's well qualified but will need to navigate RFK Jr.'s anti-vaccine agenda.

How reliable this looks

Signal and trust for Ars Technica

This source works at a rapid pace: 100% of recent stories land in the hot window, and 0% carry visible search signal.

Trusted

Reliability

92

Freshness

100

Sources in storyline

1

Related articles

More stories that share tags, source, or category context.

More from Ars Technica

Fresh reporting and follow-up coverage from the same newsroom.

Open source page